key: cord-0033197-xqf1vaoi authors: nan title: Correction, vol. 10, no. 9 date: 2004-10-03 journal: Emerg Infect Dis DOI: 10.3201/eid1010.c11010 sha: 4dcc4cda564c914e44c9a3dd9e3d379b1e8cbb91 doc_id: 33197 cord_uid: xqf1vaoi nan Correction, vol. 10, no. 9 In "SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts" by Gabriel M. Leung et al., errors occurred on p. 1654. The seventh sentence read "those who declined testing" but should have been "those who consented to testing." The corrected sentence reads as follows: However, those who consented to testing were more likely to report more frequent contact and closer relationships with SARS patients, more febrile or respiratory illness episodes since February, and a travel history to SARS-affected regions, which may have biased our seroprevalence estimate upwards. The corrected article appears online at http://www.cdc. gov/ncidod/EID/vol10no9/02-0155. htm We regret any confusion these errors may have caused. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings An outbreak of Lassa fever on the Jos plateau Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus Lassa fever. A study of 23 hospital cases Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases A prospective study of the epidemiology and ecology of Lassa fever Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescentantibody test, and virus isolation A hospital epidemic of Lassa fever in Zorzor A serological survey of Lassa fever in Liberia Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Diseases Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen Lassa fever virus in Senegal Tulane School of Public Health and Tropical Medicine, Department of Tropical Medicine, SL-17, 1430 Tulane Ave We thank Simon Mardel for his perspectives on this article.